<DOC>
	<DOCNO>NCT02098148</DOCNO>
	<brief_summary>The primary purpose study investigate whether administration xenon reduce symptom Obsessive-Compulsive Disorder ( OCD ) . Xenon naturally occur gas use clinical setting general anesthetic agent contrast agent compute tomography ( CT ) scan . Investigators believe xenon may effective reduce symptom OCD due ability reduce activity specific brain chemical call glutamate , show abnormal brain people OCD . It important understand study use placebo , inactive , treatment . In study , placebo treatment inhalation room air ( instead xenon ) . All participant receive xenon placebo treatment point course study . However , neither participant study investigator know treatment receiving .</brief_summary>
	<brief_title>Trial Low-Dose Xenon For The Treatment Of Obsessive-Compulsive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<criteria>1 . Male female age ≥ 18 ≤ 55 2 . Meets DSMIV criterion OCD primary present disorder 3 . Score ≥ 18 YBOCS screening ( Visit 1 ) . 1 . Unwillingness inability provide write informed consent . 2 . Lifetime history schizophrenia autism spectrum disorder 3 . Diagnostic Statistical Manual IV ( DSMIV ) diagnosis alcohol substance dependence , exception nicotine dependence , within three month prior screen 4 . Clinically significant medical disease include , limited , pulmonary , cardiac ( include uncontrolled hypertension ) , hepatic , renal , endocrine disorder , would increase risk participant interfere interpretation result judge principal investigator . 5 . Clinically significant neurologic disease include , limited , seizure disorder , neurodegenerative disease , history traumatic brain injury would increase risk participant interfere interpretation result judge principal investigator . 6 . Female participant positive urine pregnancy test screen 7 . Pregnancy . Females childbearing potential must use effective contraceptive method ( e.g. , abstinence , prescription oral contraceptive , contraceptive injection , doublebarrier method , male partner sterilization ) . 8 . Any screening laboratory abnormality deem clinically significant investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>